ResultsIQ

ResultsIQ › Latest results › Viyash Scientific Limited

Viyash Scientific Limited Q1 FY26 results deck summary

NSE: VIYASH · BSE: 512529

Results deck of 8 Aug 2025, summarised by AI from the filing.

SeQuent Q1 FY26 revenue ₹4,414 million, up 13.1% YoY, with Viyash merger regulatory approvals expected in the next few months.

Key takeaways

  1. Revenue Q1 FY26 revenue ₹4,414 million, up 13.1% YoY from ₹3,902 million.
  2. Merger timeline Management expects all regulatory requirements for the Viyash merger to be completed in the next few months.
  3. Margin expansion Adj. EBITDA margin improved 120 bps YoY to 13.6% in Q1 FY26.
  4. Growth drivers Growth came from superior product mix, new launches and improved operational efficiency.
  5. Merger execution Merger completion depends on regulatory requirements and NCLT process timelines.

Original filing on BSE

Viyash Scientific Limited Q1 FY27 results

As filed: Revenue ₹946 cr, EBITDA ₹178 cr, PAT ₹79.3 cr, EBITDA margin 18.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹946 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹920 cr, EBITDA ₹184 cr, PAT ₹66.4 cr, EBITDA margin 20.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹920 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.0% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹858 cr, EBITDA ₹176 cr, PAT ₹48.5 cr, EBITDA margin 20.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹858 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.7% in 30 days (Nifty 500: +2.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Viyash Scientific Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.